The vasodilatory effect of 20-HETE (20-hydroxyeicosatetraenoic acid) on lung arteries is opposite to the constrictor effect seen in cerebral and renal vessels. These observations raise questions about the cellular localization of 20-HETE forming isoforms in pulmonary arteries and other tissues. Using in situ hybridization we demonstrate for the first time CYP4A (a family of enzymes catalyzing synthesis of 20-HETE from the substrate arachidonic acid) mRNA in pulmonary arterial endothelial and smooth muscle cells, bronchial smooth muscle and epithelial cells, type I epithelial and macrophages in adult male rat lungs. Moreover, we detect CYP4A protein in rat pulmonary arteries and bronchi as well as cultured endothelial cells. Finally, we identify endogenously formed 20-HETE using fluorescent HPLC techniques, as well as the capacity to convert arachidonic acid into 20-HETE in pulmonary arteries, bronchi and endothelium. These data show that 20-HETE is an endogenous product of several pulmonary cell types and is localized to tissues that optimally position it to modulate physiologic functions such as smooth muscle tone or electrolyte flux.
INTRODUCTION
Localization of CYP4A in the lung is critical because unlike in most tissue beds where 20-HETE is a potent vasoconstrictor of resistance vessels (9, 15) , it dilates microvessels in the lung (1, 17, 18, 48, 49) . In addition, dramatic increases in capacity to synthesize 20-HETE during pregnancy in rabbit lungs has been recognized for years (27, 36) and more recently, its synthesis has been reported in human peripheral lung tissue (1) . The extensive phospholipid content and large surface area of the pulmonary vascular bed and airways have therefore recently prompted much interest in the localization of 20-HETE and enzymes that synthesize it in the lung.
Formed by ω-hydroxylation of arachidonic acid (AA), 20-HETE synthesis is catalyzed by a number of cytochrome P450 (CYP450) enzymes of the 4A, 4B and 4F families (10, 20, 35, 41) . Within the group of CYP450 4A, four members, 4A1, 4A2, 4A3 and 4A8 are known to be expressed in rat tissue (10, 14, 20, 41) . CYP4A enzymes are regulated in pathological conditions (22) and the catalytic activity of CYP 4A1 to convert AA to 20-HETE is approximately 10 times more than CYP4A2 or 4A3 (31) . There is such a high degree of homology between members of this family that the only molecular tool available to distinguish specific members is in vitro reverse-transcription followed by polymerase chain reactions using short stretches of unique primers (16) . Only recently have the cell types responsible for the formation of 20-HETE in the lung been investigated in any detail. We have identified the source of CYP4A immunospecific protein, mRNA and 20-HETE production in peripheral lung tissue of the rabbit (49) . The enzymes were detected in small and large PAs, airways, and smooth muscle cells from small PAs showing a wide distribution of CYP4A in rabbit lung. Semi-quantitative comparisions have revealed greater levels of immunospecific protein in small (external diameter 400 µm and less) versus large vessels (49) .
We explored the localization and tissue sources of CYP4A and 20-HETE in rat lungs because of availability of better molecular tools for rat enzymes as well as the fact that the only known physiological-genomics initiative to correlate genotype with vascular phenotypes is under study using in-bred strains of rats (4, 11, 44) . In addition, we were interested in examining cross-species pulmonary-specific expression of CYP4A. This report describes endogenous 20-HETE present in airway and vasculature as well as detailed localization of CYP 4A1 and 4A2 mRNAs (in situ hybridization studies) and proteins in specific cell-types of rat lungs.
METHODS

Assay for synthesis of 20-HETE from AA by airway and PA microsomes or primary cultures of bovine pulmonary artery endothelial cells (PAECs).
The lungs from rats (Sprague Dawley males, 6 weeks old) were harvested under anesthesia. Bronchi and PAs were carefully dissected and assiduously separated from surrounding adventitial tissue under a dissecting microscope until only very smooth, glistening, white tissues was visible. Each type of tissue (airways or vessels) was separately pooled and homogenized using a hand held tissue homogenizer. Microsomes from whole lung homogenates, isolated cells or vessels, were prepared by differential centrifugation in a modification of methods previously reported (1) . Sequential centrifugations at 9,000g (10 minutes) and 100,000 g for 1.5 hours were performed to generate a microsomal pellet. Protein was quantified according to the method of Bradford (2) . Microsomes were separately resuspended in assay buffer (100 mM KPO 4 (iii) Riboprobe synthesis Antisense and sense riboprobes were generated after sequencing, by in vitro transcription using sets of restriction enzymes (BamHI or EcoRV)
and RNA polymerases (T7 or Sp6 ). Riboprobes were labeled with digoxigenin-11-UTP (Boehringer-Mannheim, Indianapolis) according to the manufacturer's instructions.
(iv) Cryostat sectioning and fixing The vascular beds of the lungs were perfused by injection of 15ml RNase-free cold phosphate buffered saline (PBS; 140 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 , pH 7.4) into right ventricle of an anesthetized rat, after which the lung was removed. Frozen 8 µm lung sections were cut using a cryostat, mounted on slides and fixed with 4% paraformaldehyde followed by washes for 5 min in 2xSSC (1x SSC contains 150 mM NaCl, 15 mM Na citrate, pH 7.0).
(v) Hybridization. The sections were placed in a humidified chamber, covered for 30 min at 50 0 C with 50 µl pre-hybridization solution containing 50% formamide, 5x SSC, 5x
Denhardt's reagent, and 100 µg/ml denatured, sheared herring sperm DNA, then probed with the labeled riboprobe ( Immunohistochemical staining of endothelial cells. Lungs were flushed, fixed and sectioned as described above. After blocking overnight with 5% BSA in PBS with 0.1% Triton X-100, they were incubated with a primary antibody against rat PECAM-1 Distribution of CYP4A1 mRNA in the lung. In order to precisely localize expression of one of the major enzyme families that catalyze conversion of AA to 20-HETE, we probed frozen sections of rat lung with ribo-probes derived from the coding sequences of CYP4A1 and 4A2 cDNA, which were subcloned in the plasmid pCR II.
The inserted fragments were confirmed to be CYP4A1 and 4A2 by DNA sequencing, and probes were prepared from them as described in METHODS. In situ hybridization with these probes revealed the presence of CYP4A-specific signal in a number of cell types as shown in Figure 3 A-L.
Bronchi. Intense staining within the smooth muscle in the bronchi was apparent with the CYP4A1 and CYP4A2 antisense probes, which were used to detect complimentary CYP4A mRNA sequence. The results suggest that the main source of CYP4A in the airways is the smooth muscle. Interestingly, specific staining was also detected in the epithelial lining of the airways. This is readily observed under higher magnification as seen in Figures Inspection with higher magnification ( figure 3D ) revealed the presence of specific staining in endothelial cells of medium and small pulmonary arteries. CYP4A expression has not been reported previously in endothelial cells from any tissue beds other than lungs of pregnant female rabbits, and was therefore examined more closely. Care was taken not to damage the endothelial linings during perfusion of the lung. Smaller vessels in the section that were cut at angles favoring exposure of the endothelium showed very clear staining of endothelial cells, as marked by arrows in Figure 3E . The sections were counterstained with antibody for the endothelial-specific marker PECAM-1 ( Figure 3F) to confirm the identity of the cells. The results were also confirmed by carrying out
Western analysis with cultured endothelial cells (see below). Thus CYP4A is expressed in both vascular smooth muscle and endothelial cells of rat pulmonary arteries.
Peripheral lung: Examination of rat lung sections with the CYP4A1 and 4A2
antisense riboprobes after in situ hybridization showed dense staining in flattened parenchymal cells of the alveoli. Sections were counterstained with BPL and MPA lectins, which bind to type I and type II pneumocytes respectively. Alveolar macrophages are also stained by MPA ( figure 3H ). These data demonstrate that type I pneumocytes frequently and type II pneumocytes rarely express CYP4A specific mRNAs ( Figures 3I-L) . In addition, interstitial and alveolar macrophages also contained CYP4A specific signal ( Figures 3G and H) . 
